Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-19-002018

Chief Financial Officer sold 10,000 shares at an average $60.75 ($607,539)

From the SEC's structured data for this filing

Trades in this filing

Vasista Vittal · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-21 Sale : show line 1 in the form −8,300 $60.64 $503,312 230,915 D
2019-03-21 Sale : show line 2 in the form −1,700 $61.31 $104,227 229,215 D
Open-market sales · 10,000 sh · avg $60.75 · $607,539
Loading xslF345X03/primarydocument.xml…